Cargando…
Incomplete Susac syndrome exacerbated after natalizumab
Autores principales: | Zhovtis Ryerson, Lana, Kister, Ilya, Snuderl, Matija, Magro, Cynthia, Bielekova, Bibiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582900/ https://www.ncbi.nlm.nih.gov/pubmed/26445727 http://dx.doi.org/10.1212/NXI.0000000000000151 |
Ejemplares similares
-
Pharmacodynamics of natalizumab extended interval dosing in MS
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2020) -
Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015) -
Imaging Features of Susac Syndrome on High-Resolution Intracranial Vessel Wall MRI
por: Yahyavi-Firouz-Abadi, Noushin, et al.
Publicado: (2021) -
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
por: Ryerson, Lana Zhovtis, et al.
Publicado: (2019) -
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy
por: Gattringer, Thomas, et al.
Publicado: (2014)